Researchers Created Immortalized Human Liver Cell Lines
The new IL-HEP models overcome limitations of primary cells and cancer-derived alternatives for drug testing.
Updated on Sept. 25, 2026 in Life Sciences
Live Poll
Do you believe new laboratory cell models improve the reliability of medical research?
Scientists have generated two immortalized, non-cancer human hepatocyte cell lines, known as IL-HEP1 and IL-HEP2. These cell lines provide a more stable platform for predictive in vitro studies in pharmacology and toxicology.
Why it matters
Primary human hepatocytes are hindered by short lifespans and rapid functional decline, while cancer-derived lines often possess altered metabolic gene expression. This new model offers a more reliable alternative for research into human liver function.
The researchers employed SV40 large T antigen and human telomerase reverse transcriptase to extend the proliferative lifespan of the hepatocytes. These new lines demonstrate robust albumin secretion and CYP2C9 activity levels exceeding those of HepG2 cells.
The players
IL-HEP1 and IL-HEP2
These are the two newly generated, immortalized non-cancer human hepatocyte cell lines developed for scientific research.
HepG2
This is a commonly used human liver cancer cell line that serves as the benchmark for metabolic activity and gene expression in liver research.
The details
IL-HEP1 and IL-HEP2 cells maintain essential epithelial morphology and contact inhibition, ensuring they mimic native liver tissue more accurately than traditional cancer lines. These characteristics allow for improved metabolic assessments during drug development and regenerative medicine research.
Timeline
September 25, 2026: The research findings were published.
The Big Picture
This development represents a departure from reliance on cancer-derived cell lines, which often display impaired metabolic competence. By bridging the gap between primary cells and cancer models, this research unlocks more precise in vitro testing for drug development.
These cell lines will accelerate the development of safer pharmaceuticals by providing a more human-relevant testing platform for liver toxicity. This advancement could lead to reduced reliance on animal testing and more accurate predictions of human drug responses.
The takeaway
These immortalized liver models offer a vital tool for researchers needing stable and metabolically active human tissue samples. They serve as a reliable foundation for testing new medical treatments before they move to human clinical trials.
Further reading
For more advancements in biological modeling, explore the Life Sciences section.
More information
Access the full findings in the peer-reviewed research article.
Source note: This article includes information reported by Nature.
Live Poll
Do you believe new laboratory cell models improve the reliability of medical research?
